Sign In
Buy INVA
$21.70
+0.350 (+1.64%)
At Close: Jun 03, 2026
Will the GSK share price ever return to 2,000p?
03:39pm, Wednesday, 21'st Oct 2020
The GSK share price is too cheap, says Roland Head. He explains why he thinks plans to split the company will deliver gains for shareholders.
GlaxoSmithKline : GSK presents positive clinical data on maternal and older adults RSV candidate vaccines | MarketScreener
06:10am, Wednesday, 21'st Oct 2020GSK to launch late-stage testing of syncytial virus vaccine | MarketScreener
04:58am, Wednesday, 21'st Oct 2020Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio
12:00am, Wednesday, 21'st Oct 2020
Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the company is collaborating wit
Adial Pharmaceuticals: Opportunity Knocks For Micro Cap Targeting Multi-Billion Alcohol Use Disorder Market (NASDAQ:ADIL)
07:53pm, Saturday, 17'th Oct 2020
Adial is a tiny microcap attempting to convert an approved nausea and sickness treatment, Ondansetran, into a treatment for alcohol use disorder.
Aurinia: Ready For Voclosporin's Positive Jan. 2021 NDA Announcement, 45% Upside (NASDAQ:AUPH)
04:58pm, Wednesday, 14'th Oct 2020
Aurinia Pharmaceuticals is a late-stage clinical biopharmaceutical company aiming to develop and commercialize therapies for Lupus Nephritis (LN) and Dry Eye Syndrome (DES).
NVIDIA Vouches To Accelerate AI-Led Medical Innovations. But How?
05:30am, Monday, 12'th Oct 2020
Despite years of research and billions of dollars spent on drug discovery, 90% of the efforts fail.
Shares in this FTSE 100 champion are down 16% in a year! But would I buy big today?
07:37am, Sunday, 11'th Oct 2020
This FTSE 100 heavyweight has lost almost £14bn of market value in 12 months. What would I do with my shares now: buy, hold or sell out?
Shares in this FTSE 100 champion are down 16% in a year! But would I buy big today?
12:00am, Sunday, 11'th Oct 2020
Shares in this FTSE 100 champion are down 16% in a year! But would I buy big today?
Jean Stéphenne: "Tous les Belges ne seront pas vaccinés avant la fin de 2021"
12:07am, Saturday, 10'th Oct 2020
Jean Stéphenne, fringant septuagénaire vétéran du secteur pharmaceutique, a vécu en tant que président du développeur allemand de vaccins, CureVac, les montagnes russes mondiales à propos du c
Runners and writers: who got what in the birthday honours list
09:30pm, Friday, 09'th Oct 2020
Names from across the arts, sport, politics and science are among those recognised
Opinion | The Captain of Operation Warp Speed
09:21pm, Friday, 09'th Oct 2020
Moncef Slaoui explains how a public-private partnership is overcoming technical and bureaucratic obstacles to find a way of inoculating against Covid.
GlaxoSmithKline: An Unusual Defensive Healthcare Play (NYSE:GSK)
03:26am, Friday, 09'th Oct 2020
GlaxoSmithKline is in one of its best positions in recent history, with strong financials, a very diversified business and potential for big upside.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced 96-we
British pharma giant GlaxoSmithKline tells staff to turn off contact-tracing app while at work
02:39pm, Wednesday, 07'th Oct 2020
GlaxoSmithKline (GSK) has told around 2,500 staff in Britain to turn off a Covid-19 contact-tracing app while at work.
